AWaRe ANTIBIOTIC SURVEILLANCE MANAGEMENT AND TREATMENT DOCUMENTATION IN INPATIENT MEDICATION THERAPY MONITORING
DIVERSITY Logic Journal Multidisciplinary · 16.11.2026 · 4 (3) · 288-300
DOI: 10.61543/diversity.v4i3.214 ↗Kurz gefasst
Fachartikel in der Zeitschrift DIVERSITY Logic Journal Multidisciplinary, online erschienen am 16.11.2026. Verfasst von Ariska Defy Anggarany und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
Medication therapy monitoring can support antibiotic surveillance if records distinguish treatment decisions from pharmacy transactions. Research Purpose. To describe the Access, Watch and Reserve profile of documented inpatient antibiotics, assess the traceability of treatment decisions, and determine how including antibiotics identified only in billing changed the profile. Research Method. A retrospective descriptive audit screened inpatient forms from an Indonesian district hospital. We classified each charted systemic antibiotic outside tuberculosis regimens once per admission, assessed documentation from initiation to discharge, and repeated the classification with additional agents found only in billing records.
Findings
Fifteen episodes were screened. Nine met the criteria and contributed fourteen distinct combinations of episode and antibiotic. Watch antibiotics predominated, with ceftriaxone most frequent. All absent or conflicting start dates concerned Watch agents. Only one explicit stop date was found and it conflicted with the narrative. No documented review could be traced through to implementation. Adding antibiotics identified only in billing increased the Watch share.
Conclusion
The audit identifies third generation cephalosporins as a local priority for stewardship review. Linking treatment decisions to orders and administration records would help verify implementation and clarify discrepancies at discharge.
Zitieren
APA
Anggarany, A. D., Renaldi, F. S., Saputra, R., Irmayani, H., Fitriyani, D. A., Utami, D. P. S., Ramdhan, Z. Z., & Azi, G. A. S. M. (2026). AWaRe ANTIBIOTIC SURVEILLANCE MANAGEMENT AND TREATMENT DOCUMENTATION IN INPATIENT MEDICATION THERAPY MONITORING. DIVERSITY Logic Journal Multidisciplinary, 4(3), 288-300. https://doi.org/10.61543/diversity.v4i3.214
Vancouver
Anggarany AD, Renaldi FS, Saputra R, Irmayani H, Fitriyani DA, Utami DPS, et al. AWaRe ANTIBIOTIC SURVEILLANCE MANAGEMENT AND TREATMENT DOCUMENTATION IN INPATIENT MEDICATION THERAPY MONITORING. DIVERSITY Logic Journal Multidisciplinary. 2026;4(3):288-300. doi:10.61543/diversity.v4i3.214
BibTeX
@article{Anggarany2026,
author = {Anggarany, Ariska Defy and Renaldi, Fransiskus Samuel and Saputra, Rifaldi and Irmayani, Hanifah and Fitriyani, Deskia Amanda and Utami, Dina Putri Sri and Ramdhan, Zeashafa Zafira and Azi, Ghifa Amelia Syam Marissa},
title = {AWaRe ANTIBIOTIC SURVEILLANCE MANAGEMENT AND TREATMENT DOCUMENTATION IN INPATIENT MEDICATION THERAPY MONITORING},
journal = {DIVERSITY Logic Journal Multidisciplinary},
year = {2026},
volume = {4},
number = {3},
pages = {288--300},
doi = {10.61543/diversity.v4i3.214}
}
EUVIMED